New imidazole-2-ones and their 2-thione analogues as anticancer agents and CAIX inhibitors: Synthesis, in silico ADME and molecular modeling studies.

[1]  Y. Ammar,et al.  Antibiofilm and Anti-Quorum-Sensing Activities of Novel Pyrazole and Pyrazolo[1,5-a]pyrimidine Derivatives as Carbonic Anhydrase I and II Inhibitors: Design, Synthesis, Radiosterilization, and Molecular Docking Studies , 2023, Antibiotics.

[2]  S. Rahman,et al.  Efficient Synthesis with Green Chemistry Approach of Novel Pharmacophores of Imidazole-Based Hybrids for Tumor Treatment: Mechanistic Insights from In Situ to In Silico , 2022, Cancers.

[3]  H. El‐Ghamry,et al.  Coordination compounds of pyrazolone‐based ligand: Design, characterization, biological evaluation, antitumor efficiency, and DNA binding evaluation supported by in silico studies , 2021, Applied Organometallic Chemistry.

[4]  A. A. Abdelhamid,et al.  Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors , 2021, Molecules.

[5]  Shuang Tan,et al.  The efficiency and safety of methimazole and propylthiouracil in hyperthyroidism , 2021, Medicine.

[6]  Andreea M. Crintea,et al.  The Nanosystems Involved in Treating Lung Cancer , 2021, Life.

[7]  S. A. Ibrahim,et al.  Assessment of anti-hemolytic, cytotoxicity, antioxidant activities and molecular docking study based on thienopyrazole scaffold as pharmacophore , 2021 .

[8]  Gideon Adamu Shallangwa,et al.  Unveiling novel inhibitors of dopamine transporter via in silico drug design, molecular docking, and bioavailability predictions as potential antischizophrenic agents , 2021, Future Journal of Pharmaceutical Sciences.

[9]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[10]  S. A. Ibrahim,et al.  Green routes for the synthesis of new pyrazole bearing biologically active imidiazolyl, pyridine and quinoxaline derivatives as promising antimicrobial and antioxidant agents , 2021, Journal of the Iranian Chemical Society.

[11]  S. Dedhar,et al.  Interplay of Carbonic Anhydrase IX With Amino Acid and Acid/Base Transporters in the Hypoxic Tumor Microenvironment , 2020, Frontiers in Cell and Developmental Biology.

[12]  Santosh Kumar,et al.  Novel Quinolone Substituted Imidazol-5(4H)-ones as Anti-inflammatory, Anticancer Agents: Synthesis, Biological Screening and Molecular Docking Studies , 2020 .

[13]  E. Nice,et al.  Overcoming cancer therapeutic bottleneck by drug repurposing , 2020, Signal Transduction and Targeted Therapy.

[14]  S. A. Ibrahim,et al.  Design, synthesis, biological evaluation and molecular docking study based on novel fused pyrazolothiazole scaffold , 2020, Journal of the Iranian Chemical Society.

[15]  Zi-Ning Cui,et al.  TEMPO‐Mediated Synthesis of N ‐(Fluoroalkyl)imidazolones via Reaction of Imidazoles with Iodofluoroacetate , 2020 .

[16]  Hsin-Jung Li,et al.  Development of therapeutic antibodies for the treatment of diseases , 2020, Journal of Biomedical Science.

[17]  C. Supuran,et al.  Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents , 2020, Journal of enzyme inhibition and medicinal chemistry.

[18]  H. Becker.  Carbonic anhydrase IX and acid transport in cancer , 2019, British Journal of Cancer.

[19]  K. Williams,et al.  Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers , 2019, International journal of molecular sciences.

[20]  G. Bupesh,et al.  Molecular docking based virtual screening of carbonic anhydrase IX with coumarin (a cinnamon compound) derived ligands , 2019, Bioinformation.

[21]  S. A. Ibrahim,et al.  An Eco‐friendly Synthesis and Biological Screening of Fused Heterocyclic Compounds Containing a Thiophene MoietyviaGewald Reaction , 2019, Journal of Heterocyclic Chemistry.

[22]  Y. Shaked.  The pro-tumorigenic host response to cancer therapies , 2019, Nature Reviews Cancer.

[23]  G. Ciofani,et al.  Innovative approaches for cancer treatment: current perspectives and new challenges , 2019, Ecancermedicalscience.

[24]  Mohamed A. Abdelrahman,et al.  Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity. , 2019, Bioorganic chemistry.

[25]  E. Banoglu,et al.  Optimisation by Design of Experiment of Benzimidazol-2-One Synthesis under Flow Conditions , 2019, Molecules.

[26]  F. Hawaiz,et al.  Synthesis, characterization, antioxidant power and acute toxicity of some new azo-benzamide and azo-imidazolone derivatives with in vivo and in vitro antimicrobial evaluation. , 2019, Bioorganic chemistry.

[27]  Chung‐Ming Sun,et al.  One-pot synthesis of 4-arylidene imidazolin-5-ones by reaction of amino acid esters with isocyanates and α-bromoketones. , 2019, Organic & biomolecular chemistry.

[28]  Massimo Libra,et al.  Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium , 2018, Front. Pharmacol..

[29]  C. Supuran,et al.  The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy , 2018, Journal of enzyme inhibition and medicinal chemistry.

[30]  M. Abdel-Bakky,et al.  Design, Synthesis and Antiproliferative Activities of Oxidative Stress Inducers Based on 2-Styryl-3,5-dihydro-4H-imidazol-4-one Scaffold. , 2018, Chemical & pharmaceutical bulletin.

[31]  S Joshua Swamidass,et al.  Modeling Small-Molecule Reactivity Identifies Promiscuous Bioactive Compounds , 2018, J. Chem. Inf. Model..

[32]  Shashank Mishra,et al.  In silico Pharmacokinetic, Bioactivity and Toxicity study of Some Selected Anti-asthmatic Agents , 2018, International Journal of Pharmaceutical Sciences and Drug Research.

[33]  Leonardo L G Ferreira,et al.  From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases. , 2018, Anais da Academia Brasileira de Ciencias.

[34]  Gisbert Schneider,et al.  Automating drug discovery , 2017, Nature Reviews Drug Discovery.

[35]  Hiroki Nagai,et al.  Cancer prevention from the perspective of global cancer burden patterns. , 2017, Journal of thoracic disease.

[36]  S. A. Ibrahim,et al.  Microwave Assisted Synthesis of Fused Thiazoles in Multicomponent System and Their in vitro Antitumor, Antioxidant, and Antimicrobial Activities , 2017 .

[37]  C. Supuran,et al.  Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII. , 2016, Bioorganic & medicinal chemistry.

[38]  Vincent Zoete,et al.  A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules , 2016, ChemMedChem.

[39]  R. Dass,et al.  Synthesis, antimicrobial and anti-inflammatory activities of some novel 5-substituted imidazolone analogs , 2016 .

[40]  R. McKenna,et al.  A sucrose-binding site provides a lead towards an isoform-specific inhibitor of the cancer-associated enzyme carbonic anhydrase IX. , 2015, Acta crystallographica. Section F, Structural biology communications.

[41]  Xuemei Wang,et al.  Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia? , 2015, Future oncology.

[42]  B. Mahon,et al.  Targeting Carbonic Anhydrase IX Activity and Expression , 2015, Molecules.

[43]  Johan Ulander,et al.  Computational Prediction of Drug Solubility in Fasted Simulated and Aspirated Human Intestinal Fluid , 2014, Pharmaceutical Research.

[44]  C. Supuran,et al.  Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect. , 2014, Chemical communications.

[45]  P. Bhatt,et al.  Synthesis and pharmacological evaluation of novel 1-(piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one derivatives as potential antimicrobial agents , 2014, Medicinal Chemistry Research.

[46]  Ling Zhang,et al.  Comprehensive Review in Current Developments of Imidazole‐Based Medicinal Chemistry , 2014, Medicinal research reviews.

[47]  B. Trofimov,et al.  Three-component reaction of imidazoles, cyanophenylacetylene, and chalcogens: stereoselective synthesis of 3-alkenyl-2-imidazolethiones and -selones , 2014 .

[48]  Edward W. Lowe,et al.  Computational Methods in Drug Discovery , 2014, Pharmacological Reviews.

[49]  Abdel-Ghany A. El-Helby,et al.  Design, Synthesis and in Vivo Anti-inflammatory Activities of 2,4-Diaryl-5-4H-imidazolone Derivatives , 2012, Molecules.

[50]  J. Savjani,et al.  Pharmaceutical importance and synthetic strategies for imidazolidine-2-thione and imidazole-2-thione derivatives. , 2011, Pakistan journal of biological sciences : PJBS.

[51]  E. Ebenso,et al.  Computational Simulation and Statistical Analysis on the Relationship Between Corrosion Inhibition Efficiency and Molecular Structure of Some Phenanthroline Derivatives on Mild Steel Surface , 2011, International Journal of Electrochemical Science.

[52]  K. Dawood,et al.  Synthesis, reactions, and biological activity of 4,5-diarylimidazole-2-thiones (Review) , 2010 .

[53]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[54]  C. Piutti,et al.  A Submarine Journey: The Pyrrole-Imidazole Alkaloids † , 2009, Marine drugs.

[55]  Peter Ertl,et al.  Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions , 2009, J. Cheminformatics.

[56]  Andrea Scozzafava,et al.  Carbonic anhydrase IX: A new druggable target for the design of antitumor agents , 2008, Medicinal research reviews.

[57]  Toshiaki Watanabe,et al.  5-Aryl-imidazolin-2-ones as a scaffold for potent antioxidant and memory-improving activity. , 2008, Bioorganic & medicinal chemistry letters.

[58]  Daniel James,et al.  Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases , 2007, ChemMedChem.

[59]  Gerrit Sch√º√ºrmann.  Quantum Chemical Descriptors in Structure-Activity Relationships ‚Äî Calculation, Interpretation, and Comparison of Methods , 2004 .

[60]  John S. Delaney,et al.  ESOL: Estimating Aqueous Solubility Directly from Molecular Structure , 2004, J. Chem. Inf. Model..

[61]  P. Geerlings,et al.  Conceptual density functional theory. , 2003, Chemical reviews.

[62]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[63]  J. Fuentes,et al.  Fluoronucleosides, isothiocyanato C-nucleosides, and thioureylene di-C-nucleosides via cyclic sulfates. , 2002, The Journal of organic chemistry.

[64]  I. Muegge,et al.  Simple selection criteria for drug-like chemical matter. , 2001, Journal of medicinal chemistry.

[65]  J. Maxa,et al.  Drug Interactions Due to Cytochrome P450 , 2000, Proceedings.

[66]  J J Baldwin,et al.  Prediction of drug absorption using multivariate statistics. , 2000, Journal of medicinal chemistry.

[67]  B. V. Trzhtsinskaya,et al.  Imidazole-2-Thiones: Synthesis, Structure, Properties , 1991 .

[68]  C. Kaiser,et al.  Some benzyl-substituted imidazoles, triazoles, tetrazoles, pyridinethiones, and structural relatives as multisubstrate inhibitors of dopamine beta-hydroxylase. 4. Structure-activity relationships at the copper binding site. , 1990, Journal of medicinal chemistry.

[69]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[70]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[71]  Ralph G. Pearson,et al.  Absolute hardness: companion parameter to absolute electronegativity , 1983 .

[72]  J. Perdew,et al.  Density-Functional Theory for Fractional Particle Number: Derivative Discontinuities of the Energy , 1982 .

[73]  R. Parr,et al.  Electronegativity: The density functional viewpoint , 1978 .

[74]  R. Khalifah,et al.  The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. , 1971, The Journal of biological chemistry.

[75]  D. Mehta,et al.  Greener Approach as a Recent Advancement in the Synthesis of Thiadiazole , 2015 .

[76]  N. Parekh,et al.  Synthesis and microbial studies of imidazolone based azetidinone analogues , 2014 .

[77]  Juhi Nazaan,et al.  Novel 1 , 3 , 4-thiadiazole derivatives synthesis by MAOS , 2014 .

[78]  M. Meldal,et al.  Amino acid derived 1,4‐dialkyl substituted imidazolones , 2010, Biopolymers.

[79]  J. Pouysségur,et al.  Membrane-bound carbonic anhydrases are key pH regulators controlling tumor growth and cell migration. , 2010, Advances in enzyme regulation.

[80]  A. Ghose,et al.  A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.